Medical News

RSS

Institutional investors offer 50 million for Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus primarily in oncology, today announced that it has received $50 million from existing institutional investors in a previously announced registered direct offering.

23 Sep 2009

Breakthrough in the successful treatment of AMI

Medical device pioneer Stentys announced today the results on 20 patients participating in the Company’s ‘APPOSITION I’ clinical study—the world’s first to treat patients with acute myocardial infarction (AMI) via a self-expanding stent. These data were disclosed today by the study’s principal investigator, Christian Spaulding, M.D., Ph.D., to an audience of cardiologists during a Stentys-hosted satellite meeting at the Transcatheter Cardiovascular Therapeutics (“TCT”) 2009 annual scientific meeting.

23 Sep 2009

Bioscreen Instruments to be Labcyte's partner in India

Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.

23 Sep 2009

Pfizer in 2009 Working Mother 100 Best Companies list

Pfizer Inc has been named among the 2009 Working Mother 100 Best Companies for its steadfast commitment to family-friendly benefits. Pfizer and the other winning companies are pioneering programs that support families, with 100 percent offering flextime, on-site lactation and telecommuting; and 98 percent offering job-sharing and wellness programs—numbers that dwarf those seen nationwide. In addition, financial programs available to the 100 Best employees are on the rise, a much needed boost for families in today’s economy.

23 Sep 2009

Inverness Medical Innovations to raise funds for acquisition of Free & Clear

Inverness Medical Innovations, Inc. (NYSE: IMA) announced today that it intends to offer $100 million of senior notes due 2016 through a private placement, subject to market and other conditions. Inverness intends to use the net proceeds from the offering solely to fund its previous announced acquisition of Free & Clear, Inc.

23 Sep 2009

Pros and cons of the estimated Glomerular Filtration Rate

As many as 26 million Americans live with chronic kidney disease (CKD) and according to the National Institutes of Health (NIH), at least 10.4 million (or 40%) don't even know they have it. Enter the estimated Glomerular Filtration Rate (eGFR), which has become the preferred method for identifying people with CKD.

23 Sep 2009

Fourth-quarter and fiscal year end 2009 results announced by Natural Alternatives International

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.

23 Sep 2009

HRI offers in-house data resources on subscription basis

Health Research International, a leading medical products consulting firm, is pleased to announce the availability of several of its proprietary in-house data resources on a subscription basis.

23 Sep 2009

ASADI to focus on maternal and child healthcare this year

The fifth annual international conference of the African Science Academy Development Initiative (ASADI) will be held Nov. 9-11 in Accra, Ghana, in conjunction with the 50th anniversary of the Ghana Academy of Arts and Sciences. The theme of this year's conference will be improving maternal, newborn, and child health in Africa, which will be discussed by top experts from around the world.

23 Sep 2009

Autism Treatment Center of America announces Son-Rise Program lecture dates

Raun K.Kaufman, CEO of the Autism Treatment Center of America and Advisory Board Member of the United States Autism & Asperger's Association (USAAA), announces a series of lecture dates to be held this autumn in the UK. The Son-Rise Program of the Autism Treatment Center of America has assisted parents worldwide and in the UK dealing with Autism Spectrum Disorders including Alison Taylor.

23 Sep 2009

Leading oncology experts to discuss management of hematological malignancies

Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies.

23 Sep 2009

Practical and fun fitness tips for families

For parents who want to get their children away from the television or computer screen, Play It Again Sports has a simple solution: Make exercise a family affair.

23 Sep 2009

Medifacts awarded a $1.9M contract to provide cardiac safety services

MEDIFACTS INTERNATIONAL, INC., one of the largest global providers of noninvasive cardiac diagnostic services, today announced the award of a $1.9 million contract with a Global pharmaceutical company to provide comprehensive cardiac safety and efficacy services for a large late stage clinical trial.

23 Sep 2009

Study on the ranking of obstetrics and gynecology training programs

A ranking of obstetrics and gynecology training programs based on the maternal complication rates of their graduates' patients found these rankings consistent across individual types of complications, suggesting that these rates may reflect measures of overall quality, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

23 Sep 2009

Bayer Corporation in Working Mother magazine's 100 best companies list

Bayer Corporation has again been recognized by Working Mother magazine as one of the nation's 100 best companies for working mothers. This is the seventh time Bayer has appeared on the annual list.

23 Sep 2009

Research reveals balancing act between sugar-coated nanoparticles

A research team at the National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. Just like individuals in a crowd respecting other people's personal space, the particles work because they get close together, but not too close.

23 Sep 2009

Study on adults living with autism spectrum disorders in England

The first ever major study into adults living with autism was published today (Tuesday 22nd September) by the NHS Information Centre. The report, entitled 'Autism Spectrum Disorders in adults living in households throughout England 2007' was written by Professor Terry Brugha, a Consultant Psychiatrist with Leicestershire Partnership NHS Trust and Professor of Psychiatry at the University of Leicester with a team of UK researchers.

23 Sep 2009

There is no evidence to support the use of any test for ovarian cancer: NBOCC

In an Australian first, leading experts and organizations have agreed a position statement on screening for ovarian cancer, Australia's leading cause of death from gynecological malignancy.

23 Sep 2009

ESMO recognises 27 cancer centers for their excellent palliative care

The European Society for Medical Oncology is proud to announce that it has formally recognized 27 cancer centers for their commitment to providing excellent palliative care as part of the care they offer to patients.

23 Sep 2009

SEA technology to increase potency of monoclonal antibodies

Seattle Genetics, Inc. announced today the introduction of its sugar engineered antibody (SEA) technology, a novel approach to increasing the potency of monoclonal antibodies through enhanced effector function. The technology will be presented today by Dennis Benjamin, Ph.D., Senior Director, Chemistry, during the Americas Antibody Congress being held in Washington, DC.

23 Sep 2009